A randomized double blind phase III trial of Pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or following prior therapy.
|Trial Status||All trial activities ended|
Date of activation: 01-Oct-2008
Date Step1 close: 08-Mar-2010
|Data management at EORTC||Yes|
|Targeted Sample size||All Groups: 255|
|Type of cancer|
|Participating groups||EORTC Soft Tissue and Bone Sarcoma Group|